Prognostic value of Aurora kinase A (AURKA) expression among solid tumor patients: a systematic review and meta-analysis (Q27024067)

B. Li

2

1 reference

Q. Yang

3

1 reference

P. Zhang

4

1 reference

H. Wang

5

1 reference

language of work or name

1 reference

July 2015

1 reference

Japanese Journal of Clinical Oncology

published in

1 reference

volume

45

1 reference

issue

7

1 reference

page(s)

629-36

1 reference

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV058

Aurora-A - a guardian of poles

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV058

Roles of Aurora kinases in mitosis and tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV058

Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV058

Mitotic chromosomal instability and cancer: mouse modelling of the human disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV058

Functional significance of Aurora kinase A regulatory interactions with p53-ERα complex in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV058

A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV058

The clinical significance of Aurora-A/STK15/BTAK expression in human esophageal squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV058

Microarray-based screening for molecular markers in medulloblastoma revealed STK15 as independent predictor for survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV058

STK15/Aurora-A expression in primary breast tumors is correlated with nuclear grade but not with prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV058

Overexpression of Aurora-A contributes to malignant development of human esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV058

Aurora kinase A messenger RNA overexpression is correlated with tumor progression and shortened survival in head and neck squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV058

VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV058

Aurora kinase inhibitors as anti-cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV058

Phase II study of MLN8237 (alisertib), an investigational Aurora A kinase inhibitor, in patients with platinum-resistant or -refractory epithelial ovarian, fallopian tube, or primary peritoneal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV058

Phase I study of aurora A kinase inhibitor MLN8237 in advanced solid tumors: safety, pharmacokinetics, pharmacodynamics, and bioavailability of two oral formulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV058

Overexpression of the centrosomal protein Aurora-A kinase is associated with poor prognosis in epithelial ovarian cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV058

Cell-cycle-phase progression analysis identifies unique phenotypes of major prognostic and predictive significance in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV058

Aurora A is a negative prognostic factor and a new therapeutic target in human neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV058

Prognostic value of proliferation markers expression in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV058

Expression of cell cycle-associated proteins in non-muscle-invasive bladder cancer: correlation with intravesical recurrence following transurethral resection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV058

Prediction of response to combined immunotherapy with interferon-alpha and low-dose interleukin-2 in metastatic renal cell carcinoma: expression patterns of potential molecular markers in radical nephrectomy specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV058

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV058

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV058

Expression of Aurora kinases A and B in normal, hyperplastic, and malignant human endometrium: Aurora B as a predictor for poor prognosis in endometrial carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV058

DNA replication licensing factors and aurora kinases are linked to aneuploidy and clinical outcome in epithelial ovarian carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV058

Persistent expression of Aurora-A after neoadjuvant hormonal therapy as a predictor of a poor clinical outcome in patients undergoing radical prostatectomy for prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV058

CHFR expression is preferentially impaired in smoking-related squamous cell carcinoma of the lung, and the diminished expression significantly harms outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV058

Perimembrane Aurora-A expression is a significant prognostic factor in correlation with proliferative activity in non-small-cell lung cancer (NSCLC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV058

Reduced level of the spindle checkpoint protein BUB1B is associated with aneuploidy in colorectal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV058

Aurora kinase B is an independent protective factor in superficial bladder tumours with a dysfunctional G1 checkpoint.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV058

Correlation between Aurora-A expression and the prognosis of cervical carcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV058

Expression of STK15 mRNA in hepatocellular carcinoma and its prognostic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV058

Aurora kinases as prognostic biomarkers in ovarian carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV058

AURKA and BRCA2 expression highly correlate with prognosis of endometrioid ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV058

Prognostic significance of Aurora-A expression in human bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV058

Integrating bioinformatics and clinicopathological research of gastrointestinal stromal tumors: identification of aurora kinase A as a poor risk marker.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV058

Expression of aurora kinase A and B in chondrosarcoma and its relationship with the prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV058

Relationship of increased aurora kinase A gene copy number, prognosis and response to chemotherapy in patients with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV058

Cell cycle proteins predict recurrence in stage II and III colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV058

A comprehensive analysis of Aurora A; transcript levels are the most reliable in association with proliferation and prognosis in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV058

Aurora-A identifies early recurrence and poor prognosis and promises a potential therapeutic target in triple negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV058

Aurora kinase A (AURKA) expression in colorectal cancer liver metastasis is associated with poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV058

Spindle assembly checkpoint gene expression in childhood adrenocortical tumors (ACT): Overexpression of Aurora kinases A and B is associated with a poor prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV058

Identification of aurora kinase A as an unfavorable prognostic factor and potential treatment target for metastatic gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV058

Aurora-A contributes to cisplatin resistance and lymphatic metastasis in non-small cell lung cancer and predicts poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV058

TNK2 gene amplification is a novel predictor of a poor prognosis in patients with gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV058

Aurora kinase A is superior to Ki67 as a prognostic indicator of survival in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV058

TPX2 expression is associated with cell proliferation and patient outcome in esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV058

Prognosis value of mitotic kinase Aurora-A for primary duodenal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV058